These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2747006)

  • 1. [Serum lipoprotein abnormalities in patients with nephrotic syndrome and effects of steroid therapy].
    Kohtoku N; Okuda F; Shimizu K; Takagi H; Fujii Z; Fujii H; Kusukawa R
    Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):335-44. PubMed ID: 2747006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
    N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the effects of hemodialysis on plasma lipoproteins.
    Wada M; Minamisono T; Fujii H; Morita T; Akamatsu A
    Trans Am Soc Artif Intern Organs; 1975; 21():464-72. PubMed ID: 167493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.
    Wanner C; Krämer-Guth A; Nauck M; Quaschning T; Pavenstädt H; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):39-46. PubMed ID: 8676822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipids and lipoprotein-cholesterol distribution in nephrotic syndrome patients during short term high dose steroid treatment.
    Arije A; Erasmus RT; Anjorin SA
    Cent Afr J Med; 1993 Oct; 39(10):211-5. PubMed ID: 8020077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
    Gansevoort RT; Heeg JE; Dikkeschei FD; de Zeeuw D; de Jong PE; Dullaart RP
    Nephrol Dial Transplant; 1994; 9(3):244-50. PubMed ID: 8052429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein abnormalities in adult nephrotic syndrome.
    Ongajyooth L; Sirisalee K; Laohaphand T; Parichatiganond P; Shayakul C; Nilwarangkur S
    J Med Assoc Thai; 1993 Sep; 76(9):512-20. PubMed ID: 7964258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Thalassaemia and factors affecting the metabolism of lipids and lipoproteins.
    Papanastasiou DA; Siorokou T; Haliotis FA
    Haematologia (Budap); 1996; 27(3):143-53. PubMed ID: 14653451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN; Tvorogova MG; Levitova EN; Krylova EA
    Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the clinical significance of lipoprotein (a) in nephrotic syndrome.
    Takegoshi T; Kitoh C; Haba T; Hirai J; Wakasugi T; Saga T; Yamazaki Y; Mabuchi H
    Jpn J Med; 1991; 30(1):21-5. PubMed ID: 1830908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipid and lipoprotein abnormalities in major clinical entities of renal disease.
    Wada M; Minamisono T; Akamatsu A; Okabe M; Morita T; Handa Y; Unoki T
    Contrib Nephrol; 1978; 9():61-8. PubMed ID: 668389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary cholesterol induced changes in lipid profile in patients with nephrotic syndrome and chronic renal failure.
    Jain PK; Arora RC; Agarwal N; Garg RK; Arora S; Gurbaxani RK; Sharma D
    J Assoc Physicians India; 1991 Oct; 39(10):751-3. PubMed ID: 1816199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of cholesterol in lipoprotein fractions by agarose gel electrophoresis].
    Yan SK; Ren FQ; Song YH; Lin QS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):93-6. PubMed ID: 12905830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity.
    Appel GB; Blum CB; Chien S; Kunis CL; Appel AS
    N Engl J Med; 1985 Jun; 312(24):1544-8. PubMed ID: 3858668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.
    Wanner C; Böhler J; Eckardt HG; Wieland H; Schollmeyer P
    Clin Nephrol; 1994 Mar; 41(3):138-43. PubMed ID: 8187355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
    Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
    Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.